| Elewski, Boni E |
NCT04227288: A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis |
|
|
| Completed | 4 | 6 | US | Enstilar Foam, calcipotriene and betamethasone dipropionate | University of Alabama at Birmingham, LEO Pharma | Nail Psoriasis | 10/23 | 10/23 | | |
NCT06240351: A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA) |
|
|
| Recruiting | 4 | 15 | US | Baricitinib 4 MG Oral Tablet, Olumiant | University of Alabama at Birmingham, Eli Lilly and Company | Frontal Fibrosing Alopecia | 04/25 | 12/25 | | |
| Recruiting | 3 | 1300 | Europe, Canada, Japan, US, RoW | TAK-279 | Takeda | Plaque Psoriasis | 05/26 | 05/26 | | |
NCT05124080: An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis |
|
|
| Recruiting | 1 | 20 | US | Deucravacitinib | University of Alabama at Birmingham | Nail Psoriasis | 12/25 | 02/27 | | |
| Umphrey, Heidi R |
TMIST, NCT03233191: Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer |
|
|
| Active, not recruiting | 3 | 108508 | Europe, Canada, US, RoW | Digital Mammography, Full Field Digital Mammography, FFDM, Digital Tomosynthesis Mammography, DBT, Digital Breast Tomosynthesis, Digital Tomosynthesis of the Breast, Laboratory Biomarker Analysis, Biomarker analysis, genetic analysis, PAM50 | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Canadian Cancer Trials Group (CCTG) | Breast Screening | 12/28 | 12/30 | | |
| Cantrell, Wendy |
| Recruiting | N/A | 13 | US | Inflammatory markers | University of Alabama at Birmingham | Psoriasis, Inflammation | 04/25 | 04/27 | | |
| Lapi, Suzanne E |
NCT03321045: Positron Emission Tomography (PET) Imaging with Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness |
|
|
| Recruiting | 1 | 10 | US | [89Zr]-Df-Trastuzumab, PET/MRI Imaging | University of Alabama at Birmingham | Breast Cancer | 10/27 | 10/27 | | |
NCT05183048: Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma |
|
|
| Recruiting | 1 | 14 | US | [89Zr]Panitumumab Tracer | University of Alabama at Birmingham | Head and Neck Squamous Cell Carcinoma | 03/26 | 03/26 | | |
NCT04542603: Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer |
|
|
| Withdrawn | 1 | 20 | NA | [11C]PiB and 18F-labeled DPA-714 PET scan | University of Alabama at Birmingham | Ovarian Cancer | 08/26 | 08/26 | | |
| Woodard, Stefanie |
TMIST, NCT03233191: Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer |
|
|
| Active, not recruiting | 3 | 108508 | Europe, Canada, US, RoW | Digital Mammography, Full Field Digital Mammography, FFDM, Digital Tomosynthesis Mammography, DBT, Digital Breast Tomosynthesis, Digital Tomosynthesis of the Breast, Laboratory Biomarker Analysis, Biomarker analysis, genetic analysis, PAM50 | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Canadian Cancer Trials Group (CCTG) | Breast Screening | 12/28 | 12/30 | | |
NCT04340180: Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction |
|
|
| Active, not recruiting | 1 | 20 | US | Standard of Care (SOC) gadolinium Breast MRI, reduced 1/4 dose gadolinium Breast MRI with Artificial Intelligence (AI) to aid in evaluation. | University of Alabama at Birmingham, Bracco Corporate | Breast Benign Tumor, Breast Malignant Tumor | 09/24 | 09/24 | | |
NCT04398537: The Role of Pre-deployment Retraction in Decreasing Biopsy Clip Migration During Stereotactic Breast Biopsies |
|
|
| Completed | N/A | 245 | US | 5mm retraction of clip deployment apparatus., No retraction of clip deployment apparatus. | University of Alabama at Birmingham | Breast Biopsy | 01/22 | 07/23 | | |
| Yusuf, Nabiha |
NCT05020496: Trem-1 and Ultraviolet Radiation-induced Immune Suppression |
|
|
| Active, not recruiting | 1 | 70 | US | Diphenylcyclopropenone (DPCP) | University of Alabama at Birmingham | Skin Diseases | 06/25 | 10/26 | | |
| Completed | N/A | 392 | US | Detection of single nucleotide polymorphisms (SNP) | University of Alabama at Birmingham | Skin Cancer | 09/11 | 09/11 | | |
NCT05507125: Regulation of Inflammatory Genes in Hidradenitis Suppurativa |
|
|
| Recruiting | N/A | 200 | US | Mental health | University of Alabama at Birmingham | Hidradenitis Suppurativa | 08/26 | 08/28 | | |
| Yalniz, Ceren |
NCT06294574: Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction |
|
|
| Not yet recruiting | N/A | 150 | US | HydroMARK Plus Clip | University of Alabama at Birmingham, Mammotome | Breast Neoplasm | 12/26 | 12/26 | | |
| Mooney, Quenteeria |
NCT06294574: Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction |
|
|
| Not yet recruiting | N/A | 150 | US | HydroMARK Plus Clip | University of Alabama at Birmingham, Mammotome | Breast Neoplasm | 12/26 | 12/26 | | |
